Abstract
This was a narrative review of the literature pertaining to antiretroviral adherence rates in patients with HIV, with a focus on ADHD as a potential risk for poor adherence. A connection is drawn between the cognitive symptoms of ADHD and risk factors for poor treatment adherence in HIV. Parallel associations between ADHD and poor treatment adherence in patients with diabetes are also discussed. Finally, some of the challenges in measuring medication adherence in patients with HIV are summarized. Future research may assess whether patients with comorbid ADHD and HIV have lower rates of adherence than those with HIV alone. Samples will need to be large to manage other contributing factors such as age; in our clinic, patients with HIV referred for ADHD evaluations tend to be younger than patients with HIV referred for assessment of other neurocognitive conditions. This artifact confounds attempts to compare adherence rates in patients with both ADHD and HIV versus those without, as younger age is independently associated with poorer medication compliance. Future research should also include the development of strategies to help infectious disease clinicians to measure adherence as well as the development of cognitive and behavioral strategies for improving adherence rates in patients at risk for poor medication compliance.
Similar content being viewed by others
References
Achappa, B., Madi, D., Bhaskaran, U., Ramapuram, J., Rao, S., & Mahalingam, S. (2013). Adherence to antiretroviral therapy among people living with HIV. North American Journal of Medical Sciences, 5(3), 220–223.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington VA: American Psychiatric Association.
Andrade, S. E., Kahler, K. H., Frech, F., & Chan, K. A. (2006). Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety, 15, 565–574.
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., & Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423.
Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., & Moss, A. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435–442.
Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016). Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine, 95, 1–9. Retrieved from https://journals.lww.com/md-journal/fulltext/2016/04120/Adherence_to_Antiretroviral_Therapy_and_Virologic.58.aspx.
Cassill, C. K., Joseph, J., Carrier, E., Presley, C., & Rosenstein, L. D. (2020). Exploration of factors impacting antiretroviral medication adherence rates in adults with HIV and HIV with comorbid ADHD. International Neuropsychological Society 48th Annual Meeting. Denver, CO: Cambridge University Press.
Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30(Supplement 2), S171-176.
Cohorn, C., & Rosenstein, L. D. (1998). Adult ADHD: A neuropsychological and psychosocial comparison. Archives of Clinical Neuropsychology (14th ed., pp. 123). Washington, D.C.: National Academy of Neuropsychology Annual Conference.
Duke, D. C., Freeman, K. A., Boston, B., Hirschfield, B., & Harris, M. A. (2012). Not paying attention to diabetes: ADHD and diabetes management. Diabetes, 61(Supplement 1), A210.
Flory, K., Molina, B. S., Pelham, W. E., Jr., Gnagy, E., & Smith, B. (2006). Childhood ADHD predicts risky sexual behavior in young adulthood. Journal of Clinical Child and Adolescent Psychology, 35(4), 571–577.
Gao, X., & Nau, D. P. (2000). Congruence of three self-reported measures of medication adherence among HIV patients. Infectious Diseases, 34, 1117–1122.
Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. Journal of Acquired Immune Deficiency Syndrome, 58(2), 181–187.
Hilgard, D., Konrad, K., Meurers, M., Bartus, B., Otto, K.-P., Lepler, R., & Holl, R. W. (2017). Comorbidity of attention deficit hyperactivity disorder and type 1 diabetes in children and adolescents: Analysis based on the multicentre DPV registry. Pediatric Diabetes, 18, 706–713.
Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., & Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS Behavior, 11, 185–194.
Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: effect of pateint age, cognitive status, and substance abuse. AIDS, 18, S19–S25.
Holst, Y., & Thorell, L. B. (2017). Neuropsychological functioning in adults with ADHD and adults with other psychiatric disorders: The issue of specificity. Journal of Attention Disorders, 21, 137–148.
Hugen, P. W., Langebeek, N., Burger, D. M., Zomer, B., van Leusen, R., Schuurman, R., & Hekster, Y. A. (2002). Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndromes, 30, 324–334.
Johnson, M. O., Chesney, M. A., Goldstein, R. B., Remien, R. H., Catz, S., Gore-Felton, C., NIMH Healthy Living Project Team. (2006). Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV infected adults: A mediation model. AIDS Patient Care STDS, 20(4), 258–268.
Koutsilieri, E., Riederer, P., du Plessis, S., & Scheller, C. (2014). A short review on the relation between the dopamine transporter 10/10-repeat allele amd ADHD: Implications for HIV infection. Attention Deficit and Hyperactivity Disorders, 6(3), 203–209.
Kumar, S., Shekar, A., Pandiyan, K., Das, G., Nahar, A., Raveendra, K. R., & Hongally, C. (2014). Prevalence of adult attention deficit hyperactivty disorder and its correlates among recently diagnosed young males with HIV. AIDS & Clinical Research, 5, 314. https://doi.org/10.4172/2155-6113.1000314.
Lima, V. D., Harrigan, R., Bangsberg, D. R., Hogg, R. S., Gross, R., Yip, B., & Montaner, J. S. (2009). The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. Journal of Acquired Immune Deficiency Syndrome, 50, 529–536.
Lindblad, I., Engström, A. C., Nylander, C., & Fernell, E. (2017). Adolescents with type 1 diabetes mellitus and attention-deficit/hyperactivity disorder require specific support from healthcare professionals. Acta Pediatrica, 106, 1994–1997.
McCoy, K., Waldrop-Valverde, D., Balderson, B. H., Mahoney, C., & Catz, S. (2016). Correlates of antiretroviral therapy adherence among HIV-infected older adults. Journal of the International Association of Providers of AIDS Care, 15(3), 248–255.
Miller, K. (2015). Assessment of the impact of Attention Deficit Hyperactivity Disorder on Type 1 Diabetes. Tampa: University of South Florida Scholar Commons. Retrieved from http://scholarcommons.usf.edu/etd/5744.
Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.
Olazagasti, M. A., Klein, R. G., Mannuzza, S., Belsky, E. R., Hutchison, J. A., Lashua-Shriftman, E. C., & Castellanos, F. X. (2013). Does childhood attention-deficit/hyperactivity disorder predict risk-taking and medical illness in adulthood? Journal of the American Academy of Child and Adolescent Psychiatry, 52(2), 153–164.
Pharmacy Quality Alliance. (2018). Adherence: PQA Adherence Measures. Retrieved from PQAAlliance.org: https://www.pqaalliance.org/adherence-measures.
Raebel, M. A., Schmittdiel, J., Karter, A. J., Konieczny, J. L., & Steiner, J. F. (2013). Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Medical Care, 51, S11–S21.
Rao, D., Feldman, B. J., Frederickson, R. J., Crane, P. K., Simoni, J. M., Kitahata, M. M., & Crane, H. M. (2012). A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence. AIDS Behavior, 16, 711–716.
Sanchez, L. M., Chronis, A. M., & Hunter, S. J. (2006). Improving compliance with diabetes management in young adolescents with attention-deficit/hyperactivity disorder using behavior therapy. Cognitive and Behavioral Practice, 13, 134–145.
Schoechlin, C., & Engel, R. R. (2005). Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data. Archives of Clinical Neuropsychology, 20, 727–744.
Stirratt, M. J., Remien, R. H., Smith, A., Copeland, O. Q., Dolezal, C., Krieger, D., & SMART Couples Study Team. (2006). The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behavior, 10, 483–493.
Stricker, S. M., Fox, K. A., Baggaley, R., Negussie, E., de Pee, S., Grede, N., & Bloem, M. W. (2014). Retention in care and adherence to ART and critical elements of HIV care interventions. AIDS Behavior, 18, S465–S475.
The Antiretroviral Therapy Cohort Collaboration. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. The Lancet, 4, e349–e356.
UNAIDS. (2019). Fact Sheet-Global AIDS Update. Retrieved from UNAIDS: https://www.unaids.org/en/resources/fact-sheet.
Woods, S. P., Lovejoy, D. W., & Ball, J. D. (2002). Neuropsychological characteristics of adults with ADHD: A comprehensive review of initial studies. The Clinical Neuropsychologist, 16(1), 12–34.
Young, S., Morris, R., Toone, B., & Tyson, C. (2007). Planning ability in adults with attention-deficit/hyperactivity disorder. Neuropsychology, 21(5), 581–589.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest/Competing Interests
There are no conflicts of interest to report.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rosenstein, L.D. ADHD as a Potential Risk Factor in Poor Antiretroviral Adherence Rates in HIV: A Brief Narrative Review and Suggestions for Future Research. Neuropsychol Rev 31, 683–688 (2021). https://doi.org/10.1007/s11065-021-09483-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-021-09483-7